Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05746650Recruiting
Randomised, double-blind trial of somatropin in muscle injury (4 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Difference in muscle and myotendinous junction protein synthesis in regenerating vs. control muscle at 2 years. Started Feb 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05746650.